Neurological Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Neuromodulation Devices, Detachable Coils, Liquid Embolics, and 8 more

Neurological Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Neuromodulation Devices, Detachable Coils, Liquid Embolics, and 8 more

In 2022, the global market for neurological devices was valued at $9 billion, and it is projected to reach $13.5 billion at a CAGR of 6% during the forecast period.

The complete report suite covering the global neurological device market comprises various products, such as cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, neurovascular thrombectomy management, neuromodulation devices, intrathecal pumps, and stereotactic devices.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL NEUROLOGICAL DEVICE MARKET INSIGHTS

The largest segment within the neurological device market is neuromodulation devices, which is divided among several competitors in the spinal cord stimulation and deep brain stimulation sectors. While other segments, such as vagus nerve stimulation and gastric electric stimulation, are monopolized market segments as of the current publication. However, the sacral nerve stimulation market has seen new product launches by new entrants, including Axonics.

GLOBAL NEUROLOGICAL DEVICE MARKET SHARE INSIGHTS

Out of 50+ neurological device companies analyzed, the global market share is dominated by three key players – Medtronic, Boston Scientific, Stryker.
Medtronic has held its top position in the global neurological device market, but its monopoly on several markets has been disrupted by competitors who have taken significant shares. Axonics' introduction into the sacral nerve stimulator market has impacted Medtronic's share, while Boston Scientific and Abbott's innovations have allowed them to gain substantial shares of the deep brain stimulation (DBS) market. Nevertheless, Medtronic continues to be a leader in most markets covered in this report, including liquid embolics, neurovascular stents, neurovascular thrombectomy management, and intrathecal pump, among others.

MARKET SEGMENTATION SUMMARY

This report suite covers all relevant data on the global neurological device market, but each market segment is also available as individual MedCore reports. This gives you the flexibility to access only the neurological market research that is relevant to your needs. To review these separate reports and segments, please refer to:
Global Cerebrospinal Fluid Management Market – MedCore – Includes:
CSF shunt and CSF drainage shunt segments.
Global Detachable Coil Market – MedCore – Includes:
Bare platinum detachable coils and coated coils.
Global Liquid Embolic Market – MedCore – Includes:
Liquid embolics.
Global Neurovascular Guidewire Market – MedCore – Includes:
Neurovascular guidewires.
Global Neurovascular Catheter Market – MedCore – Includes:
Over-the-wire microcatheters, flow-directed microcatheters and neurovascular guiding catheters.
Global Neurovascular Stent Market – MedCore – Includes:
Traditional neurovascular stents, flow diversion stents and intrasaccular stents.
Global Aneurysm Clip Market – MedCore – Includes:
Titanium aneurysm clips and cobalt alloy aneurysm clips.
Global Neurovascular Thrombus Management Market – MedCore – Includes:
Stent retrievers and aspiration catheters.
Global Neuromodulation Device Market – MedCore – Includes:
Spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation.
Global Intrathecal Pump Market – MedCore – Includes:
Intrathecal pumps.
Global Stereotactic Device Market – MedCore – Includes:
Stereotactic devices.

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2022-2029
Historical Data 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.